8-K - Syros Pharmaceuticals Inc. | Modeledge

Syros Pharmaceuticals Inc.

Filing type: 8-K
Filing date: Feb 27, 2025
Updated: Feb 28, 2025 · 2:15 PM

Filing

8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Board, Management or Compensation, Other Events

Exhibits

EX-99.1Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Board, Management or Compensation, Other Events